Published in Integr Blood Press Control on January 06, 2012
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study | NCT00134160
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA (1993) 6.27
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care (1998) 3.52
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 2.96
High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol (2008) 1.98
The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med (1988) 1.83
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension (2008) 1.54
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens (2007) 1.23
The pharmacokinetic profile of amlodipine. Am Heart J (1989) 1.10
Pulse pressure and progression of chronic kidney disease. J Nephrol (2010) 1.03
Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). J Am Coll Cardiol (1994) 1.00
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial. J Hum Hypertens (2010) 0.86
A comparison of coronary heart disease event rates among urban Australian Aboriginal people and a matched non-Aboriginal population. J Epidemiol Community Health (2010) 0.83
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med (2003) 7.74
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet (2011) 5.61
Retracted Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA (2013) 4.88
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol (2012) 3.15
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol (2013) 2.28
'Reverse white-coat hypertension' in older hypertensives. J Hypertens (2002) 2.17
Rate of morning increase in blood pressure is elevated in hypertensives. Am J Hypertens (2006) 2.15
Diabetes detection in Australian general practice: a comparison of diagnostic criteria. Med J Aust (2002) 2.14
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension (2007) 2.13
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension (2006) 1.90
Retracted Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med (2006) 1.71
Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg (2009) 1.69
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv (2009) 1.61
Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheter Cardiovasc Interv (2009) 1.51
Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria. Interact Cardiovasc Thorac Surg (2006) 1.48
Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes? Med J Aust (2009) 1.45
Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries. Heart Lung Circ (2010) 1.44
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study. J Hypertens (2015) 1.41
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens (2005) 1.40
Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve. J Hypertens (2014) 1.39
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. Med J Aust (2011) 1.38
Validated Assessment Tools and Maintenance of Certification in Plastic Surgery: Current Status, Challenges, and Future Possibilities. Plast Reconstr Surg (2016) 1.37
Comparing trends in BMI and waist circumference. Obesity (Silver Spring) (2010) 1.26
Trends in BMI of urban Australian adults, 1980-2000. Public Health Nutr (2009) 1.18
Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust (2006) 1.16
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv (2010) 1.14
Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol (2011) 1.07
Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension (2008) 1.05
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. J Hypertens (2009) 1.02
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol (2011) 0.95
The heart of the matter: health status of aged care clients receiving home- and community-based care. J Aging Res (2010) 0.93
Validity of self-reported hypertension: findings from the Thai Cohort Study compared to physician telephone interview. Glob J Health Sci (2013) 0.92
Sex differences in outcomes following isolated coronary artery bypass graft surgery in Australian patients: analysis of the Australasian Society of Cardiac and Thoracic Surgeons cardiac surgery database. Eur J Cardiothorac Surg (2011) 0.92
Trends in coronary artery bypass graft surgery in Victoria, 2001-2006: findings from the Australasian Society of Cardiac and Thoracic Surgeons database project. Med J Aust (2008) 0.91
Ankle-Brachial Index determination and peripheral arterial disease diagnosis by an oscillometric blood pressure device in primary care: validation and diagnostic accuracy study. BMJ Open (2012) 0.90
Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol (2004) 0.88
Critical analysis of early and late outcomes after isolated coronary artery bypass surgery in elderly patients. Ann Thorac Surg (2011) 0.88
Prevalence of underweight, overweight and obesity in urban Hanoi, Vietnam. Asia Pac J Clin Nutr (2009) 0.87
Health risk factors and the incidence of hypertension: 4-year prospective findings from a national cohort of 60 569 Thai Open University students. BMJ Open (2013) 0.87
Impact of prosthesis--patient mismatch after mitral valve replacement: a multicentre analysis of early outcomes and mid-term survival. Heart (2011) 0.86
The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol (2009) 0.85
Overview of pharmacoeconomic modelling methods. Br J Clin Pharmacol (2013) 0.84
Health-risk factors and the prevalence of hypertension: cross-sectional findings from a national cohort of 87,143 Thai Open University students. Glob J Health Sci (2013) 0.84
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol (2010) 0.84
Postoperative atrial fibrillation after isolated aortic valve replacement: a cause for concern? Ann Thorac Surg (2012) 0.83
Impact of left ventricular dysfunction on early and late outcomes in patients undergoing concomitant aortic valve replacement and coronary artery bypass graft surgery. Cardiol J (2013) 0.82
Funding linked to ongoing research: impact of the bosentan patient registry on pricing in Australia. Value Health (2011) 0.82
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens (2014) 0.82
An Australian risk prediction model for determining early mortality following aortic valve replacement. Eur J Cardiothorac Surg (2011) 0.82
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry. Med J Aust (2008) 0.81
Early and late outcomes after isolated aortic valve replacement in octogenarians: an Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Study. Eur J Cardiothorac Surg (2012) 0.81
The economic implications of treating atherothrombotic disease in Australia, from the government perspective. Clin Ther (2010) 0.81
Smoking and primary total hip or knee replacement due to osteoarthritis in 54,288 elderly men and women. BMC Musculoskelet Disord (2013) 0.81
Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms. Eur J Prev Cardiol (2012) 0.81
Nonsymmetrical double logistic analysis of ambulatory blood pressure recordings. J Appl Physiol (1985) (2004) 0.81
Quality control activities associated with registries in interventional cardiology and surgery. Heart Lung Circ (2011) 0.80
Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study. Hypertension (2010) 0.80
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry). Am J Cardiol (2008) 0.80
N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF). Eur J Heart Fail (2013) 0.80
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort. Cardiovasc Ther (2011) 0.80
Does patient gender affect outcomes after concomitant coronary artery bypass graft and aortic valve replacement? An Australian Society of Cardiac and Thoracic Surgeons Database study. Cardiology (2011) 0.80
Cardiovascular disease in Australia: calm before a new storm? Clin Exp Pharmacol Physiol (2013) 0.80
A score for the prediction of cardiovascular events in the hypertensive aged. Am J Hypertens (2011) 0.79
NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF). Int J Cardiol (2013) 0.79
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study. Am J Hypertens (2013) 0.79
Examining the signs and symptoms experienced by individuals with suspected acute coronary syndrome in the Asia-Pacific region: a prospective observational study. Ann Emerg Med (2012) 0.78
A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown) (2014) 0.78
Review on cardiovascular risk prediction. Cardiovasc Ther (2015) 0.78
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry. Cardiovasc Ther (2013) 0.78
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Am J Cardiol (2011) 0.77
Cardiovascular medication use following percutaneous coronary intervention: the Australian experience. Cardiovasc Ther (2014) 0.77
Predicting the effectiveness of prevention: a role for epidemiological modeling. J Prim Prev (2008) 0.77
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry. Am J Cardiovasc Drugs (2010) 0.77
Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87,143 Thai Open University Students. Glob J Health Sci (2015) 0.76
Forgot to fast?: The importance on plasma glucose values. Diabetes Care (2002) 0.76
Statins for people at low risk of cardiovascular disease. Lancet (2012) 0.76
Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention. Int J Cardiol (2011) 0.76
Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr Disord (2014) 0.75
Why we need a national registry in interventional cardiology. Med J Aust (2009) 0.75
Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity. Medicine (Baltimore) (2015) 0.75
Implementing Assessment Methods in Plastic Surgery. Plast Reconstr Surg (2016) 0.75
Training in mitral valve surgery need not affect early outcomes and midterm survival: a multicentre analysis. Eur J Cardiothorac Surg (2011) 0.75
Does preoperative atrial fibrillation portend a poorer prognosis in patients undergoing isolated aortic valve replacement? A multicentre Australian study. Can J Cardiol (2012) 0.75
Excellent short- and long-term outcomes after concomitant aortic valve replacement and coronary artery bypass grafting performed by surgeons in training. J Thorac Cardiovasc Surg (2012) 0.75
Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry. Clin Ther (2011) 0.75
Notice of Retraction: Ramipril Markedly Improves Walking Ability in Patients With Peripheral Arterial Disease. Ann Intern Med (2015) 0.75
Efficacy of a Procedure-Specific Education Module on Informed Consent in Plastic Surgery. Ann Plast Surg (2017) 0.75
Use of drug-eluting stents in Victorian public hospitals. Med J Aust (2006) 0.75
Cardiovascular risk factor control in Australia: current status and implications for the future. Aust Fam Physician (2005) 0.75
Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis. Am J Cardiovasc Drugs (2013) 0.75
Training surgeon status is not associated with an increased risk of early or late mortality after isolated aortic valve replacement surgery. Cardiol J (2013) 0.75
Treatment of hypertension in the elderly: new findings in older subjects. Ital Heart J (2003) 0.75
Craniofacial fracture patterns in all terrain vehicle injuries. Ann Plast Surg (2015) 0.75
Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts. J Hypertens (2016) 0.75
Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): A Multi-Center Australian Registry. EuroIntervention (2017) 0.75
Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the aged. Am J Hypertens (2005) 0.75